You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
NEW YORK (GenomeWeb News) – Merck and BGI announced today that they will collaborate on the discovery and development of biomarkers and other genomic technologies.
The biomarker diagnostics company and the school will partner on a center for research into genes, proteins, and metabolites for use in personalized cancer assays.
The NICHD program will support research into and application of biomarkers for nutrition.
The International Severe Adverse Event Consortium will collaborate with CHI's Center for Translational Research to identify genetic markers for adverse drug reactions.
Two new papers describe how pipelines relying on targeted mass spectrometry approaches can be used to narrow in on promising biomarkers that are detectable in blood samples.
Researchers aim to develop proteomic biomarkers for bile duct cancer resulting from infection by the parasite Opisthorchis viverrini.
Stemina will study brain cells differentiated from induced pluripotent stem cells created from patients with autism, compared to the same cells from age-matched children without autism.
The award from the FSRQ will fund studies to discover biomarkers for common liver conditions.
A grant in 2012 will provide $1.8 million for research focused on biomarkers for the genetic defect.
Roche will provide a range of genomics technologies to UCLA stem cell and cancer researchers to develop new disease biomarkers and targets.
A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.
US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.
According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.
In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.